Medica, which provides more than a million radiology reports each year to help NHS hospitals deliver timely diagnoses and effective care for patients, has announced it will deploy technology from medical imaging IT and cybersecurity company Sectra. 
Medisafe, a leading digital therapeutics company with seven million registered users, announced a new initiative with Everyday Health to launch new condition-specific resource centers through the Medisafe platform. With 40% of patients turning to digital resources to help manage their chronic conditions, the new digital resource centers will feature healthcare guidance, condition-specific news coverage and living-with information to support patients managing their condition. 
Visionable has renewed its offer of free video calls to connect hospital patients with their loved ones as the COVID-19 pandemic continues.
The company, which has developed a unique video collaboration platform that is used for multi-disciplinary team meetings and virtual clinics across the NHS, created Visionable Connect in the first wave, to support patients who could not receive visits from family and friends.
Leading radiologist Rizwan Malik has joined Highland Marketing's advisory board of NHS IT and health tech industry leaders.
The divisional medical director of Bolton NHS Foundation Trust and managing director of South Manchester radiology will contribute to the group's increasingly influential discussions on health tech strategy and hot topics.
Abbott (NYSE: ABT) today announced the upcoming launch of NeuroSphere™ myPath™, a digital health app designed to track and report on patient perceived pain relief and general well-being associated with spinal cord stimulation (SCS) or dorsal root ganglion (DRG) therapy. During the device trial period required before the permanent implant, the app allows patients to record their outcomes on pain and well-being while trialing their neurostimulation therapy. 
At its virtual Pharma Media Day, Bayer presented exciting progress in transforming its pharmaceutical business with breakthrough innovation in healthcare that will significantly help patients suffering from conditions that are currently still difficult to treat. The company has recently heavily invested in external innovation with an unprecedented number of more than 25 collaboration agreements and acquisitions. 
Today, the U.S. Food and Drug Administration released the agency's first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. This action plan describes a multi-pronged approach to advance the Agency's oversight of AI/ML-based medical software.